Physician profile
David Pantino
NPI 1134417462
$6,848.28
in general payments reported to CMS, 2019-2025
7 companies · $372 in 2025
The $372 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,264 · 2020: $54.31 · 2021: $167 · 2022: $1,875 · 2023: $1,056 · 2024: $59.71 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $929 · Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $929.20 |
| Food and Beverage | $558.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,431.17 | 2019-2025 | Sapien 3 Ultra Resilia, Konect Resilia |
| Abbott Laboratories | $1,602.34 | 2019 | |
| Abiomed | $1,416.22 | 2019-2025 | Impella |
| Medistim USA, INC. | $181.31 | 2019 | |
| Bolton Medical INC | $110.40 | 2025 | Thoraflex Hybrid |
| Lsi Solutions INC | $76.83 | 2021 | |
| Atricure, INC. | $30.01 | 2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Pantino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.